gold has been researched along with chloroquine in 178 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 163 (91.57) | 18.7374 |
| 1990's | 6 (3.37) | 18.2507 |
| 2000's | 2 (1.12) | 29.6817 |
| 2010's | 5 (2.81) | 24.3611 |
| 2020's | 2 (1.12) | 2.80 |
| Authors | Studies |
|---|---|
| Schönhöfer, PS | 1 |
| Mathies, H | 8 |
| Jessop, JD | 1 |
| Meyer, W; Weyerbrock, W | 1 |
| Sänger, L | 1 |
| Heimstädt, P | 1 |
| Eberl, R | 1 |
| Huskisson, EC | 2 |
| Franchimont, P; Hauwaert, CH; Heynen, G | 1 |
| Ansell, BM | 1 |
| Schaller, J | 1 |
| Bischof, P; Kaiser, H | 1 |
| Evens, RP | 1 |
| Mancinella, A | 1 |
| Bresloff, P | 1 |
| Miehle, W | 1 |
| Krebs, A | 1 |
| Altus, R; Bartuschka, B; Hoffmann, H; In der Au, A; Jäckel, R; Keitel, W; Lindau, P; Römhild, N; Rössner, B; Tanner, E; Weber, G; Wenz, W; Wessel, G; Wesser, M; Zielke, A | 1 |
| Bonioli, E; Cambiaso, R; Gemme, G; Patrone, P; Scarsi, MR; Siliato, F | 1 |
| Kruszewski, S; Pakuła, A | 1 |
| Gemme, G | 1 |
| Müller, AE; Thiele, HG | 1 |
| Isomäki, H; Martio, J | 1 |
| Bischof, P | 1 |
| Grasedyck, K | 1 |
| Milazzo, S | 1 |
| Docken, W; Kantrowitz, FG | 1 |
| DeBenedetti, C | 1 |
| Astapenko, MG; Fischer, H; Häntzschel, H; Otto, W; Römhild, N; Tautenhahn, B; Trofimowa, TM | 1 |
| Brostoff, J; Roitt, IM | 1 |
| Hansson, L; Huunan-Seppälä, A; Mattila, A | 1 |
| Meyer, W | 3 |
| Fellinger, K | 1 |
| Klein, G; Wottawa, A | 1 |
| Seitz, M | 1 |
| Jurik, AG; Møller, P | 1 |
| Hedin, U; Thyberg, J | 1 |
| Harder, T; Krahe, T; Leiendecker, U; Mattern, H | 1 |
| Karger, T; Rau, R | 1 |
| Dugowson, CE; Gilliland, BC | 1 |
| Tulzer, W | 2 |
| Husby, G; Ostensen, M | 1 |
| Brooks, PM; Needs, CJ | 1 |
| Coles, RS | 1 |
| Tsvetkova, ES | 1 |
| Clarke, S; Dawes, PT; Fisher, J; Fowler, PD; Lawton, A; Shadforth, MF | 1 |
| Rynes, RI | 1 |
| Yamamoto, K | 1 |
| Gold, DH; Henkind, P | 1 |
| Boden, BF; Böke, W | 1 |
| Braunsteiner, H; Günther, R; Huber, C; Huber, H; Michlmayr, G | 1 |
| Pazdur, J | 1 |
| Bach, GL | 1 |
| Boström, H; Whitehouse, MW | 1 |
| Calabro, JJ; Katz, RM; Maltz, BA | 1 |
| Mizushima, Y | 1 |
| Gamp, A | 1 |
| Kölle, G | 1 |
| Dawkins, PD; McArthur, JN; Smith, MJ | 1 |
| Danysz, A | 1 |
| Akimoto, T; Mizushima, Y; Tsukada, W | 1 |
| Goossens, N | 1 |
| Hazleman, BL | 1 |
| Andreev, T; Kozhukharova, M; Pilosof, T | 1 |
| Smyth, CJ | 1 |
| Behrend, T | 1 |
| Miehlke, K; Wessinghage, D | 1 |
| Albers, P; Kroeger, FJ; Weigand, H; Wessinghage, D | 1 |
| Kästner, P | 1 |
| Smukler, NM | 1 |
| Anttila, R; Koskiahde, V; Laaksonen, AL; Mäkinen, E; Rönning, O | 1 |
| Mayr, E | 1 |
| Kitridou, RC; Solomon, SD | 1 |
| Buchanan, WW; Dick, WC | 1 |
| Dodson, WH; Holley, HL | 1 |
| Henneberg, Z | 1 |
| Lendle, L | 1 |
| Gamp, A; Schilling, A | 1 |
| Adams, SS | 1 |
| Fredholm, B | 1 |
| Gheventer, N; Houli, J; Schwartz, F | 1 |
| Miehlke, K | 1 |
| Abendroth, K; Siering, H | 2 |
| Barnes, CG | 1 |
| Kafarnik, U; Kohlhardt, J; Miehlke, K; Wirth, B | 1 |
| Calabro, JJ | 2 |
| Lockie, LM | 1 |
| Dawkins, PD; Hamilton, EB; McArthur, JN; Smith, MJ | 1 |
| Jaros, Z | 1 |
| Giles, CL | 1 |
| Ondrasík, M; Svec, V | 1 |
| Digby, JW | 1 |
| Seidel, K | 1 |
| Astapenko, MG; Trofimova, TM | 1 |
| Astapenko, MG; Pavlov, VP | 1 |
| Bennett, JC; Dodson, WH; McBride, WW | 1 |
| Gukelberger, M | 1 |
| Sancilio, LF | 1 |
| Frank, O | 1 |
| Barwik-Schramm, A; Zielonka, E; Zienkiewicz, T | 1 |
| Decker, JL; Haraoui, B; Klippel, JH; Malone, DG; Schrieber, L; Steinberg, AD; Wahl, SM; Wilder, RL | 1 |
| Amos, R; Wright, V | 1 |
| Lauressergues, H; Tarayre, JP | 1 |
| Bru, M; Caillol, V; Lauressergue, H; Tarayre, JP; Vialade, M | 1 |
| Fink, Z; Havelka, S; Hoza, J; Rubín, A | 1 |
| Mackenzie, AH | 1 |
| Brooks, PM; Buchanan, WW; Kassam, Y; Kean, WF | 1 |
| Parnham, MJ | 1 |
| Halberg, P | 1 |
| Friend, DS; Hong, K; Papahadjopoulos, D; Straubinger, RM | 1 |
| Orme, ML | 1 |
| Bunch, TW; O'Duffy, JD | 1 |
| Mowat, AG | 1 |
| Baratelli, M; Mariani, L | 1 |
| Hunneyball, IM | 1 |
| Buchanan, WW; Craig, GL | 1 |
| Paulus, HE | 1 |
| Franke, M | 1 |
| Akimova, T; Ievleva, L; Isomäki, H; Kiviniemi, P; Martio, J; Mylov, N; Trofimova, T; von Essen, R | 1 |
| Kok, GA; Reijmer, CN; Tijssen, JG; van Lith, GH | 1 |
| Suschke, HJ | 1 |
| Beresten', TI; Nasonova, VA; Sidel'nikova, SM; Tarasenkova, TA; Trofimova, TM | 1 |
| Abrahamsen, TG | 1 |
| Harada, M; Itano, S; Mimura, Y; Noguchi, K; Ohishi, M; Sakisaka, S; Sata, M; Shakado, S; Yoshida, H; Yoshitake, M | 1 |
| Breedveld, FC; Dijkmans, BA; Goeei The, SG; Landewé, RB; Van Rijthoven, AW; Vergouwen, MS | 1 |
| Balber, AE; Brickman, MJ; Cook, JM | 1 |
| Ali, AA; Beg, JA; Hussain, MA; Iqbal, MP; Mehboobali, N; Rahbar, MH | 1 |
| Heimann, K; Kociok, N; Peters, S; Schraermeyer, U; Thumann, G | 1 |
| Fraile, G; Medina, R; Navarro, M; Reggio, R; Vásquez, F; Velásquez, M | 1 |
| CRISSEY, JT; MURRAY, PF | 1 |
| DENKO, CW; McCOY, FW | 1 |
| HEIDE, M | 1 |
| HURRI, L; SIEVERS, K | 1 |
| HURRI, L; SIEVERS, K; SIEVERS, UM | 2 |
| HLUSICKA, DP | 1 |
| JEFFREY, MR | 1 |
| RUGGIERO, HA | 1 |
| BOUMA, HG; DEVRIES, K; JANSZ, A; NIEWEG, HO | 1 |
| BYNOE, ML; TAYLOR-ROBINSON, D | 1 |
| ANSELL, BM; BYWATERS, EG | 1 |
| HAZAMA, T | 1 |
| KERSLEY, GD | 1 |
| FORD, DK | 1 |
| HENKIND, P | 1 |
| SCHLEGEL, B | 1 |
| BERNACKA, K; KOSSAKOWSKI, D | 1 |
| DZSINICH, A; HARMATH, F | 1 |
| LAAKSONEN, AL; SAIRANEN, E | 1 |
| BYWATERS, EG | 1 |
| DIAMOND, H; KAPLAN, D | 1 |
| BECKER, SW; REED, WB | 1 |
| Abad, MJ; Escalona, J; Fraile, G; González, E; Ilanjian, R; Navarro, M; Taylor, P; Velásquez, M | 1 |
| Afif, N; Chatelus, E; Goetz, J; Lipsker, D; Sibilia, J; Sordet, C; Sparsa, L | 1 |
| Ansari, ZA; Chakrabarti, P; Chakraborty, S; Dey, S; Joshi, P; Shanker, V; Singh, SP | 1 |
| Ansari, ZA; Chakrabarti, P; Chakraborti, S; Joshi, P; Ramirez-Vick, JE; Shanker, V; Singh, SP | 1 |
| Ali, A; Chauhan, VS; Parween, S | 1 |
| Augereau, JM; Benoit-Vical, F; Boselli, L; Fernández Álvarez, Á; Gornitzka, H; Hemmert, C; Paloque, L; Ramadani, AP | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Botelho Pereira Soares, M; Castro, W; Costa Quadros, H; de Souza Pereira, C; Dos Santos, HF; Fonta, I; Fontinha, D; Gendrot, M; Magalhaes Moreira, DR; Mosnier, J; Navarro, M; Pradines, B; Prudêncio, M; Santos De Deus Da Silva, RI; Schmitz, V | 1 |
33 review(s) available for gold and chloroquine
| Article | Year |
|---|---|
[Interactions of antirheumatic agents].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antimetabolites, Antineoplastic; Aspirin; Chloroquine; Diuretics; Drug Interactions; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Penicillamine; Phenylbutazone; Rheumatic Diseases | 1979 |
The mechanism of action of antirheumatic agents.
Topics: Acetylglucosaminidase; Adjuvants, Immunologic; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Glucuronidase; Glycosaminoglycans; Gold; Histamine H1 Antagonists; Humans; Hyaluronoglucosaminidase; Immunosuppressive Agents; Kinins; Microbial Collagenase; Penicillamine; Prostaglandin Antagonists; Protease Inhibitors; Rheumatic Diseases; Serotonin Antagonists | 1979 |
[Problems of basic therapy of rheumatic diseases with chloroquine, gold and D-penicillamine].
Topics: Aurothioglucose; Chloroquine; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Rheumatic Diseases | 1979 |
[Current status of the diagnosis and therapy of amyloidosis].
Topics: Amyloidosis; Chloroquine; Folic Acid Antagonists; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Nitrogen Mustard Compounds; Penicillamine; Phenylbutazone | 1977 |
[Basic therapy of rheumatoid arthritis].
Topics: Alkylating Agents; Antimalarials; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine | 1977 |
Miscellaneous antirheumatic drugs and their possible modes of action.
Topics: Animals; Bacteria; Cartilage, Articular; Chemotaxis, Leukocyte; Chloroquine; Collagen; Enzyme Inhibitors; Gold; Humans; Immunity; Immunoglobulins; Lysosomes; Penicillamine; Prostaglandins; Rheumatic Diseases | 1977 |
[Current status of drug therapy in chronic polyarthritis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chloroquine; Drug Therapy, Combination; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Penicillamine; Sulfasalazine | 1991 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Felty Syndrome; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leukapheresis; Lung Diseases; Lymphoid Tissue; Methotrexate; Penicillamine; Plasmapheresis; Radiotherapy; Rheumatic Diseases; Salicylates; Sjogren's Syndrome; Spinal Diseases; Vasculitis | 1986 |
Antirheumatic drug treatment during pregnancy and lactation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Chloroquine; Cyclophosphamide; Female; Fetus; Gestational Age; Gold; Humans; Infant, Newborn; Lactation; Levamisole; Milk, Human; Penicillamine; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Time Factors | 1985 |
Antirheumatic medication in pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Chloroquine; Female; Fetal Diseases; Gold; Humans; Indomethacin; Infant, Newborn; Penicillamine; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Salicylates | 1985 |
Ocular manifestations of connective tissue disease.
Topics: Adrenal Cortex Hormones; Child; Chloroquine; Connective Tissue Diseases; Eye Diseases; Female; Giant Cell Arteritis; Gold; Humans; Inflammation; Keratoacanthoma; Male; Necrosis; Sclera; Sjogren's Syndrome; Uveitis; Uveitis, Anterior | 1985 |
[Therapeutic aspects of Behcet's syndrome].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Behcet Syndrome; Chloroquine; gamma-Globulins; Glucocorticoids; Gold; Gonadal Steroid Hormones; Histamine; Humans; Immunosuppressive Agents; Middle Aged | 1971 |
Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
Topics: Adrenal Cortex Hormones; Arteritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Chloroquine; Conjunctivitis; Dermatomyositis; Eye Diseases; Eye Manifestations; Glaucoma; Gold; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Iatrogenic Disease; Indomethacin; Keratitis; Lupus Erythematosus, Systemic; Polyarteritis Nodosa; Polymyalgia Rheumatica; Retinal Diseases; Rheumatic Diseases; Sclera; Scleroderma, Systemic; Sjogren's Syndrome; Spondylitis, Ankylosing; Uveitis | 1973 |
A critical reappraisal of juvenile rheumatoid arthritis.
Topics: Agammaglobulinemia; Arthritis, Juvenile; Aspirin; Cardiomegaly; Child; Child, Preschool; Chloroquine; Exercise Therapy; Fever; Gold; Heart Failure; Home Care Services; Humans; Hypersensitivity; Indomethacin; Joints; Leukemia; Lupus Erythematosus, Systemic; Myocarditis; Pericarditis; Phenylbutazone; Prednisone; Prognosis; Purpura; Radiography; Rubella; Serum Sickness; Skin Manifestations; Splints; Synovial Fluid; Synovitis; Uveitis, Anterior; Vascular Diseases | 1971 |
[Mechanism of action of non-steroid anti-inflammatory agents].
Topics: Acid-Base Equilibrium; Adenosine Triphosphatases; Anti-Inflammatory Agents; Ascorbic Acid; Autacoids; Chloroquine; Glycosaminoglycans; Gold; Histamine H1 Antagonists; Humans; Hydrogen-Ion Concentration; Indomethacin; Inflammation; Phenylbutazone; Salicylates; Salts | 1971 |
Therapy of rheumatoid arthritis. A pyramidal plan.
Topics: Arthritis, Rheumatoid; Chloroquine; Cyclophosphamide; Glucocorticoids; Gold; Hospitalization; Hot Temperature; Humans; Hydrocortisone; Indomethacin; Orthopedic Equipment; Oxyphenbutazone; Phenylbutazone; Physical Therapy Modalities; Prednisolone | 1972 |
Rheumatoid arthritis.
Topics: Antigen-Antibody Reactions; Arthritis, Juvenile; Arthritis, Rheumatoid; Aspirin; Biopsy; Chloroquine; Gold; Humans; Hydroxychloroquine; Immunoglobulins; Lysosomes; Prednisone; Rheumatic Nodule; Rheumatoid Factor; Synovial Membrane; Synovitis; Tenosynovitis; Vascular Diseases | 1973 |
[Chronic polyarthritis. Changes--surgical and conservative treatment].
Topics: Adult; Antibody Formation; Antigen-Antibody Complex; Antineoplastic Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Arthroplasty; Bone Screws; Carpal Tunnel Syndrome; Chloroquine; Chronic Disease; Female; Gold; Humans; Immunoglobulins; Joint Prosthesis; Male; Penicillamine; Radiography; Synovectomy | 1974 |
[Antirheumatic drugs. 40].
Topics: Aminopyrine; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimalarials; Antipyrine; Camphor; Chloroquine; Dexamethasone; Esters; Flufenamic Acid; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indomethacin; Mefenamic Acid; Methylprednisolone; Nicotinic Acids; Oils, Volatile; Oxyphenbutazone; Prednisolone; Prednisone; Rheumatic Diseases; Salicylates; Triamcinolone | 1969 |
The patient with rheumatoid arthritis.
Topics: Activities of Daily Living; Arthritis, Rheumatoid; Bursitis; Chloroquine; Diagnosis, Differential; Finger Joint; Gold; Gout; Hot Temperature; Humans; Hydroxychloroquine; Methylprednisolone; Neuralgia; Osteoarthritis; Pain; Physical Examination; Physical Exertion; Physical Therapy Modalities; Prednisolone; Rest; Salicylates; Synovectomy; Triamcinolone; Wrist Joint | 1971 |
Advances in the treatment of rheumatic disorders.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Female; Flufenamic Acid; Gold; Humans; Immunosuppression Therapy; Indomethacin; Injections, Intra-Articular; Male; Mefenamic Acid; Pentazocine; Phenacetin; Phenylbutazone; Prednisolone; Propionates | 1971 |
NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chloroquine; Glucocorticoids; Gold; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Levamisole; Penicillamine; Phenotype; Synovial Membrane; Synovitis; T-Lymphocytes | 1984 |
Do drugs change the course of rheumatoid arthritis?
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; C-Reactive Protein; Chloroquine; Cyclophosphamide; Dapsone; Glucocorticoids; Gold; Humans; Levamisole; Penicillamine; Radiography; Sulfasalazine | 1980 |
Problems of antiarthritic therapy in the elderly.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Allopurinol; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Chloroquine; Female; Gold; Gout; Humans; Male; Methotrexate; Middle Aged; Osteoarthritis; Penicillamine; Probenecid | 1984 |
The pharmacology of antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Glucocorticoids; Gold; Humans; Levamisole; Penicillamine | 1984 |
Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Gold; Humans; Levamisole; Penicillamine; Prospective Studies; Radiography; Random Allocation | 1984 |
Plasma concentrations and therapeutic effect of anti-inflammatory and anti-rheumatic drugs.
Topics: Adrenal Cortex Hormones; Analgesics; Anti-Inflammatory Agents; Chloroquine; Gold; Humans; Penicillamine; Receptors, Drug; Rheumatic Diseases; Saliva; Synovial Fluid | 1982 |
Disease-modifying drugs for progressive rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Retinal Diseases | 1980 |
[Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Chloroquine; Gold; Humans; Immunity, Cellular; Immunosuppressive Agents; Levamisole; Lymphocytes; Penicillamine; Rheumatic Diseases | 1980 |
Recent developments in disease-modifying antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Levamisole; Penicillamine; Rheumatic Diseases | 1980 |
Antirheumatic drugs: clinical pharmacology and therapeutic use.
Topics: Adrenal Cortex Hormones; Analgesics; Anti-Inflammatory Agents; Antineoplastic Agents; Chloroquine; Gold; Gout; Humans; Levamisole; Penicillamine; Rheumatic Diseases | 1980 |
[THERAPY OF RHEUMATOID ARTHRITIS PARTICULARLY ON THE DRUG TREATMENT].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arthritis; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Injections, Intra-Articular; Physical Therapy Modalities; Pyrazoles; Rehabilitation; Salicylic Acid; Steroids | 1963 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
5 trial(s) available for gold and chloroquine
| Article | Year |
|---|---|
[Results of different long term treatments of patients in the early stages of rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Gold; Humans; Immunosuppressive Agents; Prednisolone; Radiography; USSR | 1976 |
[Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Dimercaprol; Gold; Gold Sodium Thiomalate; Humans; Levamisole; Organogold Compounds; Organometallic Compounds; Penicillamine; Propanols; Random Allocation; Sulfhydryl Compounds; Time Factors | 1985 |
Antimalarial drugs for rheumatoid arthritis.
Topics: Amodiaquine; Antimalarials; Arthritis, Rheumatoid; Body Weight; Chloroquine; Clinical Trials as Topic; Gold; Humans; Hydroxychloroquine; Kinetics; Penicillamine; Tablets; Vision Disorders | 1983 |
Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Gold; Humans; Levamisole; Penicillamine; Prospective Studies; Radiography; Random Allocation | 1984 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
142 other study(ies) available for gold and chloroquine
| Article | Year |
|---|---|
Gold in the treatment of rheumatoid arthritis -- why, when and how?
Topics: Arthritis, Rheumatoid; Chloroquine; Dose-Response Relationship, Drug; Gold; Gold Sodium Thiomalate; Humans; Injections, Intra-Articular; Injections, Intramuscular; Penicillamine; Time Factors | 1979 |
[Therapy of juvenile chronic polyarthritis].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Juvenile; Azathioprine; Child; Chloroquine; Education, Special; Gold; Humans; Indomethacin; Penicillamine; Phenylbutazone; Physical Therapy Modalities; Prednisolone; Salicylates | 1975 |
[Guidelines to the therapie of the most important rheumatic diseases (author's transl)].
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Chloroquine; Gold; Humans; Immunosuppressive Agents; Patient Care Planning; Penicillamine; Physical Therapy Modalities; Rheumatic Diseases; Steroids; Tissue Extracts | 1977 |
[Basic treatment for chronic polyarthritis].
Topics: Arthritis; Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Mouth Mucosa; Penicillamine | 1977 |
The place of levamisole in the armamentarium for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Levamisole; Penicillamine | 1978 |
Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Levamisole; Penicillamine | 1978 |
Some aspects of slow-acting drugs in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Dapsone; Gold; Humans; Immunosuppression Therapy; Levamisole; Penicillamine | 1979 |
Juvenile rheumatoid arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Antinuclear; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Chloroquine; Female; Gold; HLA Antigens; Humans; Infant; Infant, Newborn; Male; Middle Aged; Rheumatoid Factor; Synovitis; Uveitis, Anterior | 1977 |
[Problems of rheumatism therapy in pregnant women].
Topics: Abortion, Spontaneous; Chloroquine; Female; Gold; Humans; Hyperbilirubinemia; Indomethacin; Penicillamine; Pregnancy; Rheumatic Diseases; Salicylates; Teratoma | 1978 |
Antirheumatic agents.
Topics: Adrenal Cortex Hormones; Antimalarials; Aspirin; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indomethacin; Penicillamine; Phenylbutazone; Phenylpropionates; Rheumatic Diseases; Salicylates; Sulindac; Tolmetin | 1979 |
[The Reiter syndrome. 2. Diagnosis, therapy, prognosis].
Topics: Arthritis; Arthritis, Reactive; Chloroquine; Gold; Humans; Immunosuppressive Agents; Osteoporosis; Penicillamine; Periostitis; Physical Therapy Modalities; Prognosis; Prostheses and Implants; Spine; Synovectomy; Urethritis | 1979 |
[Drug-induced Lichen ruber planus].
Topics: Chloroquine; Gold; Humans; Lichen Planus; Methyldopa; Penicillamine; Quinine | 1979 |
[Treatment of rheumatoid arthritis cases before the study].
Topics: Adult; Aged; Arthritis, Rheumatoid; Chloroquine; Exercise Therapy; Female; Gold; Health Resorts; Hospitalization; Humans; Male; Middle Aged; Prednisolone | 1979 |
[Ocular changes in rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Child, Preschool; Chloroquine; Conjunctivitis; Eye Diseases; Female; Gold; Humans; Keratitis; Male; Penicillamine; Sclera; Uveitis; Uveitis, Anterior | 1978 |
[Evaluation of the effectiveness of anti-inflammatory treatment of rheumatoid arthritis by means of thermography].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Temperature; Chloroquine; Drug Evaluation; Female; Gold; Humans; Hydrazines; Male; Middle Aged; Podophyllin; Prednisone; Thermography; Thiosulfates | 1978 |
[Rheumatoid disease in children. Current acquisitions and considerations of the pediatrist].
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Female; Gold; Humans; Indomethacin; Male; Penicillamine; Phenylbutazone; Wissler's Syndrome | 1978 |
[On the mode of action of antirheumatic drugs (author's transl)].
Topics: Antibiotics, Antineoplastic; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Gold; Gold Sodium Thiosulfate; Humans; Methotrexate; Microsomes, Liver; Penicillamine | 1976 |
[Medical treatment of rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chloroquine; Drug Therapy, Combination; Gold; Humans; Hydroxychloroquine; Long-Term Care; Penicillamine | 1976 |
[Problems of rheumatic therapy in pregnancy (author's transl)].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Chloroquine; Female; Fetal Diseases; Gestational Age; Gold; Humans; Indomethacin; Infant, Newborn; Maternal-Fetal Exchange; Penicillamine; Pregnancy; Pregnancy Complications; Pyrazoles; Rheumatic Diseases; Salicylates | 1976 |
[Drug therapy for chronic polyarthritis].
Topics: Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine | 1977 |
The treatment of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Child; Chloroquine; Female; Gold; Humans; Hydroxychloroquine; Ibuprofen; Indomethacin; Injections, Intra-Articular; Male; Penicillamine; Phenylbutazone; Physical Therapy Modalities; Pregnancy; Pregnancy Complications; Prognosis; Salicylates | 1977 |
Specific therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Levamisole; Penicillamine | 1976 |
Medical management of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Aspirin; Chloroquine; Gold; Humans; Ibuprofen; Indomethacin; Naproxen; Occupational Therapy; Phenylbutazone; Physical Therapy Modalities | 1976 |
Juvenile rheumatoid arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Chloroquine; Female; Fever; Gold; Growth Disorders; Hepatomegaly; Humans; Male; Pericarditis; Physical Therapy Modalities; Rest; Skin Manifestations; Uveitis, Anterior | 1976 |
Cellular reactions to mycoplasma and aggregated IgG in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Antibodies, Anti-Idiotypic; Antigens, Bacterial; Arthritis, Rheumatoid; Cell Migration Inhibition; Chloroquine; Female; Gold; Humans; Male; Middle Aged; Mycoplasma; Receptors, Antigen, B-Cell; Rheumatoid Factor | 1975 |
[Drug therapy of most important rheumatic diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Gold; Humans; Penicillamine; Rheumatic Diseases | 1976 |
The content of calcium, magnesium, copper, zinc, lead and chromium in the blood of patients with rheumatoid arthritis.
Topics: Adult; Age Factors; Arthritis, Rheumatoid; Calcium; Chloroquine; Chromium; Contraceptives, Oral; Copper; Electrolytes; Female; Gold; Hemoglobins; Humans; Indomethacin; Lead; Magnesium; Male; Middle Aged; Phenylbutazone; Sex Factors; Spectrophotometry, Atomic; Stimulation, Chemical; Zinc | 1975 |
[Critical evaluation of rheumatism therapy. Basic drugs].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Evaluation Studies as Topic; Gold; Humans; Penicillamine; Podophyllin | 1975 |
[The drug spectrum in rheumatoid arthritis therapy].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Cortisone; Gold; Humans; Immunosuppressive Agents; Penicillamine; Psychotropic Drugs | 1975 |
[Differential indications in rheumatism therapy on the basis of well-known drug side effects].
Topics: Arthritis, Rheumatoid; Azathioprine; Chloroquine; Glucocorticoids; Gold; Humans; Lupus Erythematosus, Systemic; Penicillamine | 1975 |
[The effect of so-called basic therapeutics and symptomatically effective antirheumatic drugs on the enzymes of DNA synthesis and DNA repair].
Topics: Apazone; Arthritis, Rheumatoid; Chloroquine; Cyclophosphamide; DNA; DNA Repair; Gold; Humans; Ketoprofen; Mutation; Phenothiazines; Polynucleotide Ligases | 1975 |
Atrioventricular conduction time in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Atrioventricular Node; Cardiomegaly; Chloroquine; Electrocardiography; Female; Gold; Heart Conduction System; Humans; Male; Middle Aged | 1985 |
Receptor-mediated endocytosis of immunoglobulin-coated colloidal gold particles in cultured mouse peritoneal macrophages. Chloroquine and monensin inhibit transfer of the ligand from endocytic vesicles to lysosomes.
Topics: Animals; Biological Transport, Active; Cells, Cultured; Chloroquine; Endocytosis; Furans; Gold; Horseradish Peroxidase; Immunoglobulin G; Lysosomes; Macrophages; Male; Mice; Mice, Inbred Strains; Monensin; Peritoneal Cavity; Receptors, IgG; Receptors, Immunologic | 1985 |
[Long-term course of chronic polyarthritis under basic drug therapy].
Topics: Adult; Age Factors; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Female; Follow-Up Studies; Gold; Humans; Male; Middle Aged; Penicillamine; Retrospective Studies; Rheumatoid Factor; Sex Factors; Time Factors | 1988 |
[Treatment of chronic polyarthritis with low-dose methotrexate].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Drug Evaluation; Drug Therapy, Combination; Female; Gold; Humans; Male; Methotrexate; Middle Aged; Penicillamine; Time Factors | 1988 |
[Drug therapy of chronic juvenile arthritis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthritis, Juvenile; Child; Chloroquine; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Penicillamine | 1987 |
[Chronic juvenile arthritis. Control of long-term therapy].
Topics: Adrenal Cortex Hormones; Alopecia; Anti-Inflammatory Agents; Arthritis, Juvenile; Child; Child, Preschool; Chloroquine; Gold; Humans; Leukopenia; Levamisole; Long-Term Care; Penicillamine; Pigmentation Disorders; Stomach Diseases | 1985 |
Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
Topics: Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chloroquine; Dapsone; Drug Evaluation; Gold; Humans; Penicillamine; Radiography; Rheumatoid Factor | 1986 |
Antimalarial treatment of rheumatoid arthritis: 1985 status.
Topics: Antimalarials; Arthritis, Rheumatoid; Chloroquine; Drug Combinations; Gold; Humans; Hydroxychloroquine; Kidney; Penicillamine; Retinal Diseases | 1985 |
[Eye findings in rheumatic diseases].
Topics: Adolescent; Arthritis, Juvenile; Arthritis, Reactive; Arthritis, Rheumatoid; Behcet Syndrome; Cataract; Chloroquine; Dermatomyositis; Eye Diseases; Glaucoma; Glucocorticoids; Gold; Granulomatosis with Polyangiitis; Humans; Intestinal Diseases; Lupus Erythematosus, Systemic; Polyarteritis Nodosa; Polychondritis, Relapsing; Rheumatic Diseases; Spondylitis, Ankylosing | 1974 |
[DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Chloroquine; DNA; Female; Gold; Humans; Indomethacin; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocytes; Male; Methotrexate; Methylprednisolone; Middle Aged; Penicillamine; Polyarteritis Nodosa | 1973 |
[The effect on thrombocyte function of drugs used in polyarthritis].
Topics: Adenine Nucleotides; Aorta; Arthritis; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chloroquine; Erythrocytes; Gold; Humans; Hydrocortisone; Phenylbutazone; Platelet Adhesiveness; Thrombin; Tissue Extracts | 1969 |
Adverse reactions of antirheumatic drugs.
Topics: Analgesics; Anti-Inflammatory Agents; Chloroquine; Dimethylamines; Drug Hypersensitivity; Gold; Humans; Immunosuppressive Agents; Indomethacin; Malonates; Mefenamic Acid; Penicillamine; Propionates; Prostaglandin Antagonists; Pyrazoles; Rheumatic Diseases; Salicylates; Steroids; Triazines | 1973 |
Biochemical properties of anti-inflammatory drugs. VI. The effects of chloroquine (resochin), mepacrine (quinacrine) and some of their potential metabolites on cartilage metabolism and oxidative phosphorylation.
Topics: Animals; Cartilage; Chloroquine; Glycosaminoglycans; Gold; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Oxidative Phosphorylation; Polysaccharides; Quinacrine; Quinolines; Rats; Sulfates; Sulfur Isotopes; Thiosulfates | 1965 |
[Clinical picture of rheumatic diseases. Current position of gold therapy].
Topics: Adrenal Glands; Antibody Formation; Arthritis, Rheumatoid; Chloroquine; Drug Eruptions; Drug Evaluation; Exanthema; Gold; Humans; Lysosomes; Pruritus; Stomatitis | 1974 |
Method of treatment of rheumatoid arthritis in different countries.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Chloroquine; Dimethyl Sulfoxide; England; Europe; Flufenamic Acid; Gold; Humans; Indomethacin; Injections, Intra-Articular; Japan; ortho-Aminobenzoates; Oxyphenbutazone; Phenylbutazone; Prednisolone; Salicylates; South America; United States | 1966 |
[Treatment of chronic polyarthritis].
Topics: Adrenocorticotropic Hormone; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Hydrotherapy; Immunosuppressive Agents; Indomethacin; Orthopedics; Penicillamine; Phenylbutazone; Physical Therapy Modalities; Prednisolone; Prednisone; Triamcinolone Acetonide | 1967 |
[Long term therapy of rheumatoid arthritis in children].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Juvenile; Azathioprine; Child; Chloroquine; Gold; Humans; Indomethacin; Long-Term Care; Manipulation, Orthopedic; Methotrexate; Phenylbutazone; Physical Therapy Modalities; Pyrazoles; Salicylates; Synovectomy; Uveitis, Anterior | 1970 |
The displacement of L-tryptophan and dipeptides from bovine albumin in vitro and from human plasma in vivo by antirheumatic drugs.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Blood Proteins; Cattle; Chloroquine; Dipeptides; Gold; Humans; Indomethacin; Phenylalanine; Phenylbutazone; Prednisolone; Protein Binding; Salicylates; Serum Albumin, Bovine; Tryptophan | 1971 |
A modification of rat adjuvant arthritis for testing antirheumatic drugs.
Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis; Aspirin; Carrageenan; Chloroquine; Dexamethasone; Disease Models, Animal; Female; Flufenamic Acid; Gold; Hydrocortisone; Indomethacin; Inflammation; Phenylbutazone; Prednisolone; Rats; Thiomalates | 1972 |
The effect of antiinflammatory drugs on the blood coagulation system.
Topics: Anti-Inflammatory Agents; Apazone; Aspirin; Blood Coagulation; Blood Platelets; Chloroquine; Cortisone; Gold; Humans; Indomethacin; Niflumic Acid; Penicillamine; Pyrazoles | 1974 |
Drug treatment of connective tissue disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Azathioprine; Chloroquine; Collagen Diseases; Cyclophosphamide; Gold; Humans; Immunosuppressive Agents; Indomethacin; Penicillamine; Phenacetin; Phenylbutazone | 1974 |
Structural formulae of drugs commonly used in the treatment of rheumatic disease.
Topics: Alkylating Agents; Analgesics; Anti-Inflammatory Agents; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chloroquine; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatic Diseases; Uricosuric Agents | 1973 |
[Dynamics of circulating anti-tissue antibodies and titer of rheumatoid factor in rheumatoid polyarthritis under the effect of immunosuppressive drugs, antimalarials and gold salts].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antibody Formation; Antimalarials; Arthritis, Rheumatoid; Autoantibodies; Azathioprine; Chlorambucil; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Immunosuppressive Agents; Male; Middle Aged; Rheumatoid Factor | 1972 |
[What is assured in the treatment of chronic inflammatory joint disease?].
Topics: Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Inflammation; Joint Diseases; Penicillamine; Physical Therapy Modalities | 1972 |
[Therapy of chronic polyarthritis. 1. Causal therapy, basic drug therapy].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine | 1972 |
[Operative treatment of rheumatoid arthritis and its radiography].
Topics: Arthritis, Rheumatoid; Arthrodesis; Arthroplasty; Chloroquine; Fingers; Gold; Humans; Indomethacin; Joint Prosthesis; Knee; Penicillamine; Pyrazoles; Radiography; Salicylates; Synovectomy | 1973 |
[P-phenomenon in progressive chronic polyarthritis].
Topics: Animals; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Cortisone; Gold; Gout; Immunoglobulin Fragments; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Indomethacin; Osteoarthritis; Pyrazoles; Rats; Spondylitis, Ankylosing; Synovial Fluid; Tuberculosis, Osteoarticular | 1973 |
Treatment of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Arthritis, Rheumatoid; Aspirin; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Hydroxychloroquine; Indomethacin; Male; Middle Aged; Phenylbutazone; Physical Therapy Modalities; Rest | 1974 |
[Special problems of juvenile rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Amyloidosis; Arthritis, Juvenile; Bone Development; Child; Chloroquine; Diagnosis, Differential; Eye Diseases; Female; Gold; Humans; Indomethacin; Kidney Diseases; Micrognathism | 1974 |
Iatrogenic disease in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Gold; Humans; Hydroxychloroquine; Iatrogenic Disease; Indomethacin; Phenylbutazone; Salicylates | 1971 |
[New possibilities of intraarticular therapy of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Chloroquine; Dexamethasone; Gold; Humans; Injections, Intra-Articular | 1968 |
[Critical view on drug therapy for rheumatism].
Topics: Analgesics; Animals; Anti-Bacterial Agents; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Gold; Guinea Pigs; Humans; Rabbits; Rats; Rheumatic Diseases; Rheumatic Fever; Salicylates | 1967 |
[Critic of rheumatism therapy in the practice].
Topics: Adrenal Cortex Hormones; Ambulatory Care; Arthritis, Rheumatoid; Chloroquine; Chronic Disease; Family Practice; Gold; Gout; Humans; Mineral Waters; Physical Therapy Modalities; Prednisone; Rheumatic Diseases; Salicylates; Spondylitis, Ankylosing | 1967 |
The development of an antirheumatic drug.
Topics: Adrenal Cortex Hormones; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Cats; Chloroquine; Dogs; Erythema; Furans; Gold; Humans; Immunosuppressive Agents; Nicotinic Acids; Rats; Rheumatic Diseases; Ulcer | 1971 |
[Site and mode of action of antirheumatic agents].
Topics: Anti-Inflammatory Agents; Antigens; Antilymphocyte Serum; Arthritis, Rheumatoid; Chloroquine; Glucocorticoids; Gold; Humans; Indomethacin; Lymphocytes; Lysosomes; Rheumatic Diseases; Rheumatoid Factor; Salicylates | 1971 |
[Dosage and adverse effects of commonly used antirheumatic agents].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Drug Combinations; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatic Diseases | 1971 |
[Anti-inflammatory drugs of non-steroidal type].
Topics: Animals; Anti-Inflammatory Agents; Chloroquine; Gold; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Rats; Salicylates | 1969 |
[In vitro inhibition of rheumatoid factor caused by chloroquine and gold salt].
Topics: Chloroquine; Gold; Humans; In Vitro Techniques; Latex Fixation Tests; Rheumatoid Factor | 1969 |
[Modern conception of a causal management of chronic polyarthritis].
Topics: Antigen-Antibody Complex; Arthritis; Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatoid Factor; Synovectomy | 1969 |
[Experimental studies on the effect of aristolochic acid in immunosuppressive therapy].
Topics: Animals; Antibody Formation; Bone Marrow; Chloroquine; Gold; Phenanthrenes; Plasma Cells; Prednisone; Rats; Triaziquone | 1969 |
The drug treatment of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Analgesics; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents | 1970 |
[Basic therapy of progressive chronic polyarthritis].
Topics: Aged; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine | 1970 |
Management of juvenile rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Chloroquine; Exercise Therapy; Gold; Humans; Indomethacin; Phenylbutazone; Prednisone; Rest; Splints; Uveitis, Anterior | 1970 |
Current evaluation of drugs for treating arthritis.
Topics: Acetaminophen; Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Codeine; Cortisone; Cyclophosphamide; Dextropropoxyphene; Gold; Gout; Humans; Indomethacin; Mefenamic Acid; Pentazocine; Phenylbutazone; Salicylates; Spondylitis, Ankylosing | 1971 |
Mode of action of antirheumatic drugs.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Bilirubin; Binding Sites; Blood Proteins; Chloroquine; Female; Gold; Humans; Indomethacin; Jaundice; Male; Middle Aged; Phenylbutazone; Prednisolone; Pregnancy; Protein Binding; Tryptophan | 1971 |
[Influence of drugs used in rheumatology on the blood].
Topics: Analgesics; Anti-Inflammatory Agents; Bone Marrow Diseases; Chloroquine; Corticosterone; Gold; Hematologic Diseases; Hemorrhage; Humans; Indomethacin; Phenacetin; Phenylbutazone; Salicylates | 1971 |
Ocular complications in the treatment of joint disease.
Topics: Adrenal Cortex Hormones; Adult; Allopurinol; Anti-Inflammatory Agents; Child; Chloroquine; Eye Diseases; Female; Gold; Humans; Indomethacin; Joint Diseases; Male; Phenylbutazone; Salicylates | 1971 |
[Incidence of complications in the drug treatment of ankylosing spondylitis].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Chloroquine; Copper; Female; Gold; Humans; Indomethacin; Male; Phenylbutazone; Spondylitis, Ankylosing | 1971 |
Rheumatoid arthritis: drug therapy.
Topics: Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Phenylbutazone; Prednisone; Salicylates | 1968 |
[The immunopathogenesis of chronic rheumatoid polyarhtritis and new ways of its treatment].
Topics: Adult; Aged; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Autoantibodies; Chloroquine; Drug Synergism; Female; Gold; Humans; Immunosuppressive Agents; Latex Fixation Tests; Lysosomes; Male; Middle Aged; Prednisone; Synovial Membrane; Triaziquone | 1968 |
[Long term treatment of patients with infectious nonspecific polyarthritis with gold salts in conjunction with res-okhin].
Topics: Arthritis, Rheumatoid; Chloroquine; Drug Synergism; Gold; Humans | 1968 |
[Intra-articular corticotherapy in chronic joint diseases].
Topics: Chloroquine; Chronic Disease; Gold; Humans; Hydrocortisone; Injections, Intra-Articular; Joint Diseases | 1968 |
Management of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Amitriptyline; Anxiety; Arthritis, Rheumatoid; Aspirin; Attitude of Health Personnel; Barbiturates; Chlordiazepoxide; Chloroquine; Exercise Therapy; Gold; Hospitalization; Hot Temperature; Humans; Indomethacin; Injections, Intra-Articular; Lidocaine; Mechlorethamine; Phenylbutazone; Physical Therapy Modalities; Physician-Patient Relations; Prednisolone; Rest | 1969 |
[Internal therapy of chronic polyarthritis].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Balneology; Chloroquine; Chronic Disease; Exercise Therapy; Gold; Humans; Immunosuppressive Agents; Muscles; Ultrasonic Therapy | 1969 |
Evans blue-carrageenan pleural effusion as a model for the assay of nonsteroidal antirheumatic drugs.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Carrageenan; Chloroquine; Coloring Agents; Edema; Flufenamic Acid; Foot Diseases; Gold; Indoles; Indomethacin; Penicillamine; Phenylbutazone; Pleural Effusion; Rats | 1969 |
[Experimental studies on the effect of aristolochia acid in immunosuppressive therapy].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chloroquine; Gold; Immunosuppressive Agents; Plant Extracts; Plants, Medicinal; Plasma Cells; Prednisone; Quinones; Rats | 1969 |
Gold therapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aspirin; Chloroquine; Gold; Humans; Hydroxychloroquine; Indomethacin; Phenylbutazone | 1965 |
[Drug therapy of chronic polyarthritis].
Topics: Analgesics; Arthritis, Rheumatoid; Aspirin; Chloroquine; Disability Evaluation; Glucocorticoids; Gold; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Prednisolone | 1966 |
[Biochemistry of chronic rheumatism of the joints].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Hyaluronic Acid; Hydrocortisone; Joints; Osteoarthritis; Salicylates; Synovial Fluid | 1966 |
[Effects of intravenous administration of gold salts on the tests of the acute stage of rheumatoid arthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Middle Aged; Mucoproteins; Serologic Tests | 1967 |
Action of sodium aurothiopropanol, chloroquine, D-penicillamine and levamisole on picryl chloride-delayed hypersensitivity in mice.
Topics: Chloroquine; Dimercaprol; Gold; Hypersensitivity, Delayed; Levamisole; Organogold Compounds; Organometallic Compounds; Penicillamine; Picryl Chloride; Propanols; Sulfhydryl Compounds | 1980 |
The reduction of tuberculin-induced pleurisy in the guinea-pig by a gold salt, chloroquine and D-penicillamine.
Topics: Animals; Chloroquine; Dimercaprol; Female; Gold; Guinea Pigs; Male; Mice; Organogold Compounds; Organometallic Compounds; Penicillamine; Pleurisy; Propanols; Sulfhydryl Compounds; Tuberculin | 1981 |
[Adverse effects of antirheumatics in children and adolescents].
Topics: Adolescent; Anti-Inflammatory Agents; Child; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine; Rheumatic Diseases | 1984 |
Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles.
Topics: Ammonium Chloride; Animals; Cell Line; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Chloroquine; Coated Pits, Cell-Membrane; Colloids; Endocytosis; Fluorescent Dyes; Glycerol; Gold; Hydrogen-Ion Concentration; Kidney; Liposomes; Mice; Organoids; Vacuoles | 1983 |
Slow-acting antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Humans; Levamisole; Penicillamine; Phenylacetates; Propionates | 1982 |
An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.
Topics: Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Hydroxychloroquine; Levamisole; Macular Degeneration; Male; Neoplasms; Pancytopenia; Penicillamine; Risk | 1982 |
Management of juvenile rheumatoid arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Arthritis, Juvenile; Aspirin; Child; Chloroquine; Chronic Disease; Gold; Humans; Penicillamine; Prednisone; Time Factors; Tolmetin; Uveitis, Anterior | 1981 |
[Basic therapeutic drugs for rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Immunosuppressive Agents; Penicillamine | 1981 |
Early rheumatoid arthritis in the USSR and in Finland.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Arthritis, Rheumatoid; Chloroquine; Finland; Follow-Up Studies; Gold; Humans; Middle Aged; Penicillamine; Rheumatoid Factor; USSR | 1980 |
Interpretation of the electro-oculogram of patients taking chloroquine.
Topics: Arthritis, Rheumatoid; Chloroquine; Dose-Response Relationship, Drug; Electrooculography; Eye; Gold; Humans; Time Factors | 1980 |
[Drug therapy of juvenile chronic polyarthritis].
Topics: Arthritis, Juvenile; Azathioprine; Child; Chloroquine; Glucocorticoids; Gold; Humans; Penicillamine; Physician-Patient Relations | 1980 |
[Treatment of rheumatoid arthritis with prolonged-action drugs].
Topics: Aminoquinolines; Arthritis, Rheumatoid; Chlorambucil; Chloroquine; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Penicillamine; Time Factors | 1980 |
[Principles and mechanism of action of drug therapy of rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Gold; Humans | 1980 |
Role of cytoskeleton and acidification of endocytic compartment in asialoglycoprotein metabolism in isolated rat hepatocyte couplets.
Topics: Acids; alpha-Fetoproteins; Animals; Asialoglycoproteins; Cell Separation; Chloroquine; Colchicine; Cytochalasin B; Cytoskeleton; Endocytosis; Fetuins; Gold; Horseradish Peroxidase; Liver; Male; Microscopy, Electron; Rats; Rats, Wistar | 1995 |
Antimalarial drug induced decrease in creatinine clearance.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chloroquine; Creatinine; Female; Gold; Humans; Hydroxychloroquine; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Penicillamine; Regression Analysis; Retrospective Studies | 1995 |
Low temperature reversibly inhibits transport from tubular endosomes to a perinuclear, acidic compartment in African trypanosomes.
Topics: Acids; Albumins; Animals; Biological Transport; Biomarkers; Cattle; Cell Compartmentation; Chloroquine; Cold Temperature; Concanavalin A; Endocytosis; Endosomes; Gold; Hot Temperature; Kinetics; Microscopy, Electron; Trypanosoma brucei brucei | 1995 |
Methotrexate in rheumatoid arthritis: a 2 year experience at a university hospital in Pakistan.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Drug Therapy, Combination; Female; Follow-Up Studies; Gold; Hospitals, University; Humans; Male; Methotrexate; Middle Aged; Penicillamine; Retrospective Studies; Sulfasalazine; Treatment Outcome | 1998 |
Melanin granules of retinal pigment epithelium are connected with the lysosomal degradation pathway.
Topics: Animals; Cattle; Cell Culture Techniques; Chloroquine; Culture Techniques; Gold; Lysosomes; Melanins; Melanosomes; Microspheres; Pigment Epithelium of Eye; Rats; Rats, Long-Evans; Rod Cell Outer Segment | 1999 |
Effects of gold-chloroquine complexes on respiratory burst of polymorphonuclear leukocytes.
Topics: Adenosine Triphosphate; Cell Survival; Cell-Free System; Chloroquine; Dose-Response Relationship, Drug; Gold; Humans; In Vitro Techniques; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate | 2002 |
A comparison of chloroquine and gold in the treatment of lupus erythematosus.
Topics: Chloroquine; Gold; Lupus Erythematosus, Systemic | 1956 |
The conservative management of rheumatoid arthritis. A review of experience with drugs other than gold and corticosteroids.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Chloroquine; Glucocorticoids; Gold; Phenylbutazone; Salicylates | 1962 |
[The treatment of chronic polyarthritis].
Topics: Adrenal Cortex Hormones; Arthritis; Chloroquine; Gold; Humans; Pyrazoles; Salicylates | 1963 |
[Diseases of the rheumatic type and therapeutic viewpoints].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Chloroquine; Gold; Phenylbutazone; Physical Therapy Modalities; Rheumatic Diseases; Steroids | 1963 |
Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Psychotherapy, Multiple | 1963 |
Combined therapy of rheumatoid arthritis with gold and chloroquine. II. Evaluation of the side effects.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Psychotherapy, Multiple | 1963 |
[TREATMENT WITH GOLD SALTS AND ANTIMALARIALS].
Topics: Antimalarials; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Chloroquine; Gold; Humans; Salts | 1963 |
MANAGEMENT OF RHEUMATOID ARTHRITIS IN THE ELDERLY PATIENT.
Topics: Adrenal Cortex Hormones; Aged; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Gastrointestinal Hemorrhage; Geriatrics; Gold; Humans; Hydroxychloroquine; Prognosis; Rehabilitation; Rest; Social Work; Surgical Procedures, Operative; Toxicology | 1963 |
[TREATMENT OF COLLAGEN DISEASES].
Topics: Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases; Chloroquine; Collagen Diseases; Dermatomyositis; Dexamethasone; Edetic Acid; Gold; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Polyarteritis Nodosa; Prednisolone; Prednisone; Scleroderma, Systemic; Splenectomy; Toxicology; Triamcinolone | 1963 |
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.
Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fixation Tests; Drug Hypersensitivity; Gold; Humans; Hydroxychloroquine; Meprobamate; Phenacetin; Phenylbutazone; Probenecid; Purpura; Purpura, Thrombocytopenic; Quinacrine; Rheumatic Diseases; Splenectomy; Toxicology | 1963 |
TO-DAY'S DRUGS. DRUGS FOR RHEUMATOID DISORDERS. 3.
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Dosage Forms; Gold; Humans; Pharmacology; Toxicology | 1964 |
[IS THE GOLD TREATMENT DESPITE ITS SIDE-EFFECTS PRESENTLY STILL JUSTIFIED?].
Topics: Adrenal Glands; Arthritis; Arthritis, Rheumatoid; Chloroquine; Gold; Toxicology | 1963 |
RHEUMATOID ARTHRITIS (STILL'S DISEASE).
Topics: Adolescent; Adrenal Cortex Hormones; Arthritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Blood Sedimentation; Child; Chloroquine; Diagnosis, Differential; England; Genetics, Medical; Gold; Hemoglobins; Humans; Infant; Iridocyclitis; Mortality; Pathology; Phenylbutazone; Physical Therapy Modalities; Radiography; Salicylates; Splints; Spondylitis; Spondylitis, Ankylosing | 1963 |
A COMPARATIVE STUDY OF THE EFFECTS OF GOLD CHLOROQUINE AND COMBINED GOLD-CHLOROQUINE THERAPY IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Hypersensitivity; Eosinophilia; Gold; Toxicology | 1963 |
THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Corneal Opacity; Electroretinography; Eye; Eye Diseases; Gold; Humans; Hydroxychloroquine; Retina; Toxicology | 1964 |
NON-STEROID ANTIRHEUMATIC DRUGS.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Biomedical Research; Chloroquine; Codeine; Drug Therapy; Gold; Leukocyte Count; Oxyphenbutazone; Phenacetin; Phenylbutazone; Rheumatic Fever; Toxicology | 1964 |
OCULAR COMPLICATIONS OF DRUG TREATMENT OF RHEUMATIC DISORDERS.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Corneal Ulcer; Drug Therapy; Eye; Eye Diseases; Eye Manifestations; Gold; Humans; Iatrogenic Disease; Iritis; Retina; Rheumatic Diseases; Toxicology | 1964 |
[THE TREATMENT OF CHRONIC POLYARTHRITIS].
Topics: Arthritis; Chloroquine; Drug Therapy; Gold; Indomethacin; Phenylbutazone; Prednisone; Salicylates; Toxicology | 1964 |
[ANTI-RHEUMATIC DRUGS AND ACUTE PHASE TESTS IN THE TREATMENT OF CHRONIC PROGRESSIVE RHEUMATISM].
Topics: Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Blood Proteins; Chloroquine; Drug Therapy; Gold; Rheumatic Diseases | 1964 |
[ON MANGANESE TREATMENT OF PRIMARY CHRONIC POLYARTHRITIS].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Chlorides; Chloroquine; Gold; Humans; Manganese | 1964 |
THE RESULTS OF GOLD THERAPY IN JUVENILE RHEUMATOID ARTHRITIS.
Topics: Adolescent; Arthritis; Arthritis, Juvenile; Biomedical Research; Child; Chloroquine; Drug Therapy; Gold; Humans; Infant; Injections, Intramuscular; Physical Therapy Modalities; Sulfasalazine | 1964 |
[DAMAGE DUE TO LONG-TERM THERAPY. 1. ANTIRHEUMATIC AGENTS].
Topics: Adrenal Cortex Hormones; Aminopyrine; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Therapy; Gold; Humans; Prednisone; Pyrazoles; Rheumatic Diseases; Rheumatic Fever; Salicylates; Toxicology | 1964 |
CHILD CARE IN GENERAL PRACTICE. RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS.
Topics: Adolescent; Arthritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Child Care; Chloroquine; Diagnosis; Drug Therapy; Family Practice; General Practice; Gold; Humans; Penicillins; Prednisone; Rheumatic Fever; Salicylates | 1965 |
RHEUMATOID ARTHRITIS AND PREGNANCY.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Therapy; Female; Gold; Humans; Hydrocortisone; Indomethacin; Phenylbutazone; Pregnancy; Pregnancy Complications; Salicylates; Toxicology | 1965 |
Lichenoid drug eruptions from gold, chloroquine and chlorothiazide.
Topics: Chloroquine; Chlorothiazide; Drug Eruptions; Gold; Humans; Lichen Planus | 1962 |
Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability. Comparison with auranofin.
Topics: Animals; Antirheumatic Agents; Auranofin; Cell Proliferation; Cell Survival; Chloroquine; Female; Gold; Indicators and Reagents; Inflammation; Interleukin-6; Leukocytes; Lipopolysaccharides; Mice; Microscopy, Fluorescence; Monocytes; Neutrophils; Phytohemagglutinins; Respiratory Burst; Serum Albumin; Tumor Necrosis Factor-alpha | 2006 |
Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?
Topics: Antibodies, Antinuclear; Antirheumatic Agents; Chloroquine; Female; Gold; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome | 2011 |
Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin.
Topics: Animals; Antimalarials; Binding Sites; Borohydrides; Cattle; Chloroquine; Fatty Acids; Gold; Microscopy, Electron, Transmission; Models, Molecular; Nanoparticles; Particle Size; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Sulfhydryl Compounds; Thermodynamics; Tryptophan; Warfarin | 2011 |
The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Proliferation; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gold; Humans; Metal Nanoparticles; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Non-natural amino acids containing peptide-capped gold nanoparticles for drug delivery application.
Topics: Aminoisobutyric Acids; Animals; Antimalarials; Antineoplastic Agents; Cell Line; Cell Survival; Chloroquine; Doxorubicin; Drug Carriers; Drug Delivery Systems; Gold; HeLa Cells; Humans; Metal Nanoparticles; Mice; Peptides; Phenylalanine | 2013 |
Antiplasmodial activities of gold(I) complexes involving functionalized N-heterocyclic carbenes.
Topics: Animals; Antimalarials; Cell Survival; Chlorocebus aethiops; Chloroquine; Crystallography, X-Ray; Gold; Inhibitory Concentration 50; Methane; Molecular Structure; Organometallic Compounds; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2016 |
A Novel Hybrid of Chloroquine and Primaquine Linked by Gold(I): Multitarget and Multiphase Antiplasmodial Agent.
Topics: Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Gold; Humans; Malaria; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Primaquine; Structure-Activity Relationship | 2021 |